Literature DB >> 16046665

Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: a two-stage hypothesis for regulation of MSC fate.

Carl A Gregory1, Joni Ylostalo, Darwin J Prockop.   

Abstract

Mesenchymal stem cells (MSCs) are clonal, plastic adherent cells from bone marrow that can differentiate into various tissue lineages, including osteoblasts, adipocytes, chondrocytes, myoblasts, hepatocytes, and possibly even neural cells. Because MSCs are multipotent and their numbers are easily expanded in culture, there has been much interest in their clinical potential for tissue repair and gene therapy. Consequently, numerous studies have been carried out demonstrating the migration and multiorgan engraftment potential of MSCs in animal models and in human clinical trials. Understanding the mechanisms behind MSC cell fate determination is not easy, because the molecular processes that drive engraftment and differentiation are complex. Even in an in vitro system, the molecular cues necessary to induce differentiation are not easily identified or reproduced. In this Perspective, we emphasize the importance of microenvironmental factors in culture and suggest that MSC differentiation in vitro is regulated by a two-stage mechanism involving preconditioning by factors in the culture microenvironment followed by response to soluble differentiating factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046665     DOI: 10.1126/stke.2942005pe37

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  57 in total

Review 1.  Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors.

Authors:  Todd Meyerrose; Scott Olson; Suzanne Pontow; Stefanos Kalomoiris; Yunjoon Jung; Geralyn Annett; Gerhard Bauer; Jan A Nolta
Journal:  Adv Drug Deliv Rev       Date:  2010-10-13       Impact factor: 15.470

2.  Keratinocyte proximity and contact can play a significant role in determining mesenchymal stem cell fate in human tissue.

Authors:  Raja K Sivamani; Michael P Schwartz; Kristi S Anseth; R Rivkah Isseroff
Journal:  FASEB J       Date:  2010-09-16       Impact factor: 5.191

Review 3.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

Review 4.  Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

5.  Macromolecular crowding amplifies adipogenesis of human bone marrow-derived mesenchymal stem cells by enhancing the pro-adipogenic microenvironment.

Authors:  Xiu Min Ang; Michelle H C Lee; Anna Blocki; Clarice Chen; L L Sharon Ong; H Harry Asada; Allan Sheppard; Michael Raghunath
Journal:  Tissue Eng Part A       Date:  2013-12-03       Impact factor: 3.845

6.  Circulating progenitor cells in chronic lung disease.

Authors:  Borna Mehrad; Michael P Keane; Brigitte N Gomperts; Robert M Strieter
Journal:  Expert Rev Respir Med       Date:  2007-08       Impact factor: 3.772

7.  The effects of human keratinocyte coculture on human adipose-derived stem cells.

Authors:  Bommie F Seo; Ki J Kim; Min K Kim; Jong W Rhie
Journal:  Int Wound J       Date:  2014-08-05       Impact factor: 3.315

Review 8.  Mesenchymal stem cells in the treatment of type 1 diabetes mellitus.

Authors:  Jana Katuchova; Denisa Harvanova; Timea Spakova; Rastislav Kalanin; Daniel Farkas; Peter Durny; Jan Rosocha; Jozef Radonak; Daniel Petrovic; Dario Siniscalco; Meirigeng Qi; Miroslav Novak; Peter Kruzliak
Journal:  Endocr Pathol       Date:  2015-05       Impact factor: 3.943

9.  Surface Tethering of Inflammation-Modulatory Nanostimulators to Stem Cells for Ischemic Muscle Repair.

Authors:  Jiayu Leong; Yu-Tong Hong; Yu-Fu Wu; Eunkyung Ko; Svyatoslav Dvoretskiy; Jye Yng Teo; Byoung Soo Kim; Kyeongsoo Kim; Hojeong Jeon; Marni Boppart; Yi Yan Yang; Hyunjoon Kong
Journal:  ACS Nano       Date:  2020-04-13       Impact factor: 15.881

10.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.